Excited to head to ASCO GI next week to present our work on the prognostic and predictive role of ctDNA in stage III colon cancer in the 80702 clinical trial. Thanks to @ASCO for kindly considering our late-breaking abstract. @ALLIANCE_org @DanaFarber @NateraOncology #GI25
Jonathan A. Nowak
@jonathan_nowak
Molecular and GI pathologist. Assoc director, BWH Center for Advanced Molecular Diagnostics. @BrighamWomens @BWHPath @DanaFarber @harvardmed Views are my own.
142 Following 408 Followers 221 Posts
Latest posts 5
Thrilled for the Wolpin-Nowak lab to be part of the correlative science team for this cohort! An amazing opportunity to conduct great science using human specimens to rapidly improve RAS inhibitor use in PDAC.
๐๐ฟ๐ฒ๐ฎ๐ธ ๐๐๐ง๐ค๐ช๐๐ ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ Verified account @break_cancer Dec 19, 2024
We are excited to have launched an expanded Phase 1 trial cohort for pancreatic cancer with Revolution Medicines. This trial uses serial biopsies and blood samples to analyze tumor response to RMC-6236 at an unprecedented level of cellular detailView quoted post on X
Read more here: tinyurl.com/5n7zjevs
#PancreaticCancer#RadicalCollaboration
Thank you #AMPath24 Program Cmte, all our exhibitors & sponsors, speakers, attendees, volunteers, and the @AMPath team for another truly amazing meeting. Thank you #Vancouver for being such a wonderful host city. Save the dates now for #AMPath25 Boston! #beantownView quoted post on X
So many opportunities to learn from long range sequencing approaches. Great perspective on the current landscape and personal experience presented by @sedlazeck @BCM_HGSC at #AMPath24. @AMPath